Source link : https://newshealth.biz/health-news/unprecedented-survival-seen-with-maintenance-tarlatamab-for-sclc-in-early-study/
(MedPage Today) — The combination of tarlatamab (Imdelltra) and a PD-L1 inhibitor after first-line chemo-immunotherapy showed promise as a maintenance therapy in patients with extensive-stage small cell lung cancer (ES-SCLC), with a manageable… Source link : https://www.medpagetoday.com/meetingcoverage/iaslc/117402 Author : Publish date : 2025-09-10 18:32:00 Copyright for syndicated content belongs to the linked Source.
The post ‘Unprecedented’ Survival Seen With Maintenance Tarlatamab for SCLC in Early Study first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-10 18:32:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8